KCNA5 and atrial fibrillation: Similarly, atrial Pluricytes express KCNA5 at levels comparable to primary atrial cardiomyocytes and may thus be used to screen for substances that bind to or modulate the atrial-associated ion channel KV1.5 (KCNA5), a target proposed for the treatment of atrial fibrillation [43].